Can Creatine Cause an Enlarged Prostate?

No direct evidence from human studies shows that creatine supplementation causes an enlarged prostate. The concern traces back to a single small study that found creatine raised levels of dihydrotestosterone (DHT), a hormone involved in prostate growth, but subsequent and larger research has not confirmed that finding. The connection between creatine and prostate health is more nuanced than internet forums suggest, and the existing clinical data, while still limited, points away from a meaningful risk.

Where the Worry Came From

Almost all of the anxiety about creatine and prostate health originates from a 2009 study of 20 college-aged rugby players in South Africa. After seven days of a creatine loading phase, the players’ DHT levels rose by 56 percent, and after a further 14 days at a lower maintenance dose, DHT remained about 40 percent above baseline. Testosterone itself did not change, but the ratio of DHT to testosterone shifted upward as well.¹ That detail caught widespread attention because DHT is the specific androgen most strongly linked to benign prostatic hyperplasia, or BPH, the noncancerous swelling of the prostate that affects many men as they age.

The logic seemed straightforward: if creatine pushes DHT up, and DHT drives prostate enlargement, then creatine could be a hidden contributor to prostate problems. That reasoning spread quickly through fitness communities and was picked up by supplement-skeptic health outlets. But the study itself had real limitations. Twenty young athletes is a tiny sample. The participants were also undergoing intense rugby training, which by itself can shift hormone profiles. And no one measured prostate size, urinary symptoms, or any prostate-related outcome at all. The study was about hormones in the blood, not about what those hormones did to the prostate.

What Newer Research Shows About Creatine and DHT

The 2009 rugby study stood largely alone for years as the primary evidence connecting creatine to DHT. That changed with a 2025 randomized controlled trial specifically designed to test whether creatine supplementation alters DHT. In this 12-week study, researchers found no changes in raw DHT concentrations in the creatine group compared to placebo. Both groups experienced some hormonal shifts over time, including increases in total testosterone and decreases in free testosterone, but these changes happened regardless of whether participants took creatine or not.² The study was designed around hair loss concerns, another DHT-linked worry, but its hormonal measurements are directly relevant to prostate questions too.

This matters because the 2009 finding was never replicated. In science, a single unreplicated result from a small study is a hypothesis, not a conclusion. The 2025 trial was longer, used a controlled design with a placebo group, and measured DHT directly rather than relying solely on ratios. Its failure to find any creatine-specific DHT increase substantially weakens the hormonal case against creatine.

How DHT Actually Drives Prostate Growth

To understand why the DHT question matters, it helps to know what DHT does in the prostate. Testosterone circulates through the bloodstream, and when it reaches prostate tissue, an enzyme converts it into DHT. This converted form binds more powerfully to the androgen receptor inside prostate cells and drives gene activity that promotes cell growth. In younger men, this process helps the prostate develop and function normally. In older men, the same process can fuel excessive growth, thickening the gland and squeezing the urethra in ways that cause the urinary symptoms associated with BPH.³

The drugs most commonly prescribed to shrink an enlarged prostate, finasteride and dutasteride, work by blocking the enzyme that converts testosterone to DHT. The fact that lowering DHT treats BPH is strong evidence that DHT genuinely matters for prostate growth. So the concern about creatine was never irrational. If creatine reliably and substantially raised DHT over long periods, that would be a legitimate reason to worry. The question is whether it actually does, and the current weight of evidence suggests it does not.

It is also worth noting that the relationship between circulating DHT and prostate growth is not as simple as “more DHT equals bigger prostate.” The conversion from testosterone to DHT happens largely inside prostate tissue itself, and local tissue-level DHT concentrations do not always track neatly with what shows up in a blood test. A temporary bump in serum DHT after a week of creatine loading, even if it were real, would not necessarily translate into meaningful prostate tissue effects over months or years.

Creatine in Men With Prostate Cancer

Perhaps the most telling evidence comes from a setting where prostate risk would matter the most: men who already have prostate cancer. A double-blind randomized trial gave creatine or placebo to 30 men with prostate cancer who were receiving androgen deprivation therapy, a treatment that deliberately suppresses testosterone and DHT to slow cancer growth. Both groups also did supervised resistance exercise three days per week. After the study period, no adverse events were reported from either the creatine supplementation or the exercise program.⁴

This trial was small and was primarily designed to look at muscle and strength outcomes rather than prostate-specific endpoints. But the fact that researchers felt comfortable giving creatine to prostate cancer patients, and that no safety signals appeared, tells you something about the clinical community’s assessment of the risk. If there were strong theoretical or empirical reasons to believe creatine worsened prostate disease, this trial would not have been approved by an ethics board.

The Broader Safety Picture

Creatine is one of the most studied sports supplements in existence, and a 2025 analysis that examined side-effect data across clinical trials found no meaningful difference in reported side effects between creatine and placebo groups. Total side-effect frequency was about 4.6 percent for creatine users and 4.2 percent for placebo, a gap that was not statistically significant. Markers of kidney function and overall health showed no differences either.⁵

Prostate enlargement or urinary symptoms do not appear as a recurring concern in this safety literature. That does not prove creatine is harmless for the prostate, since most creatine trials study younger, healthier populations and do not specifically measure prostate outcomes. But it does mean that if creatine were causing noticeable prostate problems, you would expect those effects to show up somewhere in the side-effect reporting of hundreds of trials. They have not.

Creatine Metabolism Inside Prostate Cancer Cells

There is a separate line of research that sometimes gets tangled into this conversation but addresses a fundamentally different question. Scientists have found that aggressive prostate cancer cells show enhanced creatine metabolism, meaning they rely on creatine-related energy pathways more than normal cells do. In mouse models of aggressive prostate cancer, creatine treatment was associated with increased tumor cell proliferation. Conversely, a creatine analog called cyclocreatine, which blocks normal creatine metabolism, dramatically reduced intracellular creatine levels and suppressed cancer cell growth in both lab dishes and animal models.⁶

This research is about finding new cancer treatment strategies by targeting how tumor cells generate energy. It does not mean that taking creatine supplements causes or worsens prostate cancer in humans. Cancer cells also consume glucose voraciously, but nobody concludes that eating carbohydrates causes cancer. Tumor cells exploit whatever metabolic fuel is available, and the fact that blocking their access to creatine slows their growth in mice is a finding about cancer biology, not about supplement safety. The distinction matters because these studies sometimes get cited on forums as proof that creatine “feeds” prostate cancer, which is a misreading of what the research actually tested.

Related work has shown that an enzyme involved in creatine-based energy production, ubiquitous mitochondrial creatine kinase, becomes downregulated as prostate cancer advances. More aggressive cancer cells shift toward a different energy-production pathway.⁷ This is further evidence that creatine metabolism changes inside cancer, but it says nothing about whether dietary creatine intake influences whether cancer develops in the first place.

The Creatinine Confusion

Another source of misunderstanding involves creatinine, a breakdown product of creatine. When you take creatine supplements, your body produces more creatinine, which shows up in blood and urine tests. Creatinine is routinely measured as a marker of kidney function, and elevated levels can alarm a doctor who does not know the patient is supplementing. This sometimes leads to unnecessary concern and further testing.

The connection to prostate health is indirect but worth knowing about. One study found a U-shaped relationship between serum creatinine levels and high-risk prostate cancer prognosis, meaning both unusually low and unusually high creatinine levels were associated with worse outcomes.⁸ But creatinine levels reflect many things: muscle mass, kidney function, hydration, diet. Creatine supplementation raises creatinine through a completely different mechanism than the kidney disease or muscle wasting that typically drives abnormal creatinine readings. The clinical significance of supplement-induced creatinine elevation for prostate prognosis is unknown, and it would be a stretch to draw any practical conclusions from it. The practical takeaway is simpler: if you supplement creatine and get blood work, tell your doctor so they interpret the creatinine number correctly.

What About Supplement Contamination

One underappreciated risk with any supplement, creatine included, has nothing to do with the active ingredient itself. Research into supplement contamination has found that a surprisingly high proportion of products contain ingredients not listed on the label. A study of protein and pre-workout supplements used by high school athletes found that over half of protein products and three-quarters of pre-workout products contained at least one ingredient not regulated for dietary supplements. Some contained compounds that could not even be identified through standard chemical databases.⁹

This is relevant because some of the anecdotal reports of prostate symptoms from creatine users could plausibly be explained by contaminants in lower-quality products rather than by creatine itself. Prohormones, which are steroid precursors that genuinely can affect androgen levels and prostate tissue, have been found as undeclared ingredients in various supplement categories. If you are concerned about prostate health and choose to take creatine, sticking with a product that has been independently tested by a third-party certification program reduces this risk. Pure creatine monohydrate from a reputable manufacturer is a very different product from a “creatine blend” in a proprietary formula with unidentifiable ingredients.

Resistance Training, DHT, and the Exercise Confound

People who take creatine tend to be people who lift weights intensely, and resistance training itself can raise androgen levels in muscle tissue. Animal research has shown that resistance-trained subjects had higher levels of DHT in skeletal muscle compared to sedentary controls.¹⁰ This is a rat study and cannot be directly extrapolated to human prostate outcomes, but it highlights an important confound: when someone reports prostate symptoms while taking creatine, it can be difficult to separate the effect of the supplement from the effect of the training program, from the effect of aging, from the effect of other supplements in the stack.

BPH is extremely common in men over 50, affecting roughly half of that age group to some degree. Many men who supplement creatine will develop prostate enlargement simply because they reach the age where it becomes common. Attributing that to creatine without controlled evidence is the kind of pattern-matching that leads to false cause-and-effect conclusions. The same logic applies to anecdotal reports: the base rate of prostate symptoms in middle-aged men is high enough that coincidence explains a lot.

What to Do If You Have Prostate Concerns

If you already have BPH or are being monitored for prostate issues, the honest answer is that no one can guarantee creatine is risk-free for your specific situation, because the specific question has never been studied in a rigorous, long-term trial focused on prostate outcomes. What the available evidence shows is that creatine does not reliably raise DHT in controlled studies, that it has been used safely in men with prostate cancer, and that broad safety analyses reveal no prostate-related signal.

A reasonable approach is to discuss creatine use with whatever clinician manages your prostate health, particularly so they can interpret any blood work accurately. Creatine’s effect on creatinine readings is well-documented and completely benign, but it can mimic kidney problems on paper if the doctor is not aware you are supplementing. For PSA testing, no known interaction between creatine and PSA levels has been established, so supplementation should not affect that screening process. If you are taking a 5-alpha-reductase inhibitor for BPH, there is no published evidence of an interaction with creatine, but the combination has not been formally studied either. The gaps in the research are not themselves evidence of danger, but they do mean you are making a decision with incomplete information, which is true of most supplement choices.

Why the Research Gap Exists

It might seem strange that such a widely used supplement has so little prostate-specific research. The reason is partly economic and partly demographic. Creatine is cheap, generic, and unpatentable in its monohydrate form, so there is no pharmaceutical company with a financial incentive to fund large prostate-outcome trials. The people who use creatine most heavily tend to be younger men focused on athletic performance, not the older demographic where prostate issues become relevant. And the existing safety data, while not prostate-specific, has been reassuring enough that funding agencies have not prioritized the question. Researchers tend to chase signals, and creatine has not produced one.

The 2009 DHT finding could have been that signal, but its failure to replicate in subsequent research has dampened enthusiasm for pursuing the prostate angle further. Science often works this way: a striking initial result generates concern, follow-up studies fail to confirm it, and the field moves on without ever running the definitive large-scale trial that would settle the question for good. For consumers, this leaves an unsatisfying but honest state of knowledge: no proven risk, no proof of zero risk, and a plausible mechanism that newer evidence increasingly suggests does not actually operate as originally feared.